CERA Working Groups are interdisciplinary teams that aim to deepen our understanding of emerging, high priority, or understudied ELSI issues using innovative approaches. Working Group outcomes include new research, educational materials, publications for scholarly and lay audiences, online tools, and events. CERA selects one or two issue-based Working Groups biannually and awards each support for up to $20,000 in project costs.
The CERA Working Groups for 2020-2022 are:
- Novel Gene Therapies for Pediatric and Young Adults with Sickle Cell Disease: Engaging Patient and Parent Stakeholders Working Group
- Developing Resources for DNA Testing at the Border: BorderDNA Working Group